- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/56 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Patent holdings for IPC class C07D 215/56
Total number of patents in this class: 294
10-year publication summary
|
24
|
28
|
14
|
22
|
17
|
11
|
11
|
15
|
13
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1600 |
44 |
| Bayer Animal Health GmbH | 219 |
9 |
| Vertex Pharmaceuticals (europe) Limited | 17 |
9 |
| Japan Tobacco Inc. | 3596 |
9 |
| Active Biotech AB | 58 |
7 |
| Gilead Sciences, Inc. | 2032 |
7 |
| Proteostasis Therapeutics, Inc. | 70 |
6 |
| City of Hope | 994 |
5 |
| Sunshine Lake Pharma Co., Ltd. | 597 |
5 |
| Boehringer Ingelheim International GmbH | 4642 |
4 |
| Allergan, Inc. | 2347 |
4 |
| California Institute of Technology | 3977 |
4 |
| Laurus Labs Limited | 100 |
4 |
| Takeda Pharmaceutical Company Limited | 2708 |
3 |
| Concert Pharmaceuticals, Inc. | 247 |
3 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1371 |
3 |
| Council of Scientific & Industrial Research | 1427 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 875 |
3 |
| Teva Pharmaceutical Industries Ltd. | 783 |
3 |
| Zentiva k.s. | 574 |
3 |
| Other owners | 156 |